tracing of the individuals and also to monitor them. It can predict
the future course of this disease and likely reappearance.
IV) Projection of cases and mortality
This technology can track and forecast the nature of the virus
from the available data, social media and media platforms, about
the risks of the infection and its likely spread. Further, it can predict
the number of positive cases and death in any region. AI can help
identify the most vulnerable regions, people and countries and take
V) Development of drugs and vaccines:
AI is used for drug research by analyzing the available data on
COVID-19. It is useful for drug delivery design and development.
This technology is used in speeding up drug testing in real-time,
where standard testing takes plenty of time and hence helps to
accelerate this process signi?cantly, which may not be possible by a
human [6,7]. It can help to identify useful drugs for the treatment of
COVID-19 patients. It has become a powerful tool for diagnostic test
designs and vaccination development [9e11]. AI helps in devel-
oping vaccines and treatments at much of faster rate than usual and
is also helpful for clinical trials during the development of the
VI) Reducing the workload of healthcare workers
Due to a sudden and massive increase in the numbers of pa-
tients during COVID-19 pandemic, healthcare professionals have a
very high workload. Here, AI is used to reduce the workload of
healthcare workers [12e17]. It helps in early diagnosis and
providing treatment at an early stage using digital approaches and
decision science, offers the best training to students and doctors
regarding this new disease [18,19]. AI can impact future patient care
and address more potential challenges which reduce the workload
of the doctors.
VII) Prevention of the disease
With the help of real-time data analysis, AI can provide updated
information which is helpful in the prevention of this disease. It can
be used to predict the probable sites of infection, the in?ux of the
virus, need for beds and healthcare professionals during this crisis.
AI is helpful for the future virus and diseases prevention, with the
help of previous mentored data over data prevalent at different
time. It identi?es traits, causes and reasons for the spread of
infection. In future, this will become an important technology to
?ght against the other epidemics and pandemics. It can provide a
preventive measure and ?ght against many other diseases. In
future, AI will play a vital role in providing more predictive and
Arti?cial Intelligence is an upcoming and useful tool to identify
early infections due to coronavirus and also helps in monitoring the
condition of the infected patients. It can signi?cantly improve
treatment consistency and decision making by developing useful
algorithms. AI is not only helpful in the treatment of COVID-19
infected patients but also for their proper health monitoring. It
can track the crisis of COVID-19 at different scales such as medical,
molecular and epidemiological applications. It is also helpful to
facilitate the research on this virus using analyzing the available
data. AI can help in developing proper treatment regimens, pre-
vention strategies, drug and vaccine development.
Declaration of competing interest
 Haleem A, Javaid M, Vaishya. Effects of COVID 19 pandemic in daily life. Curr
Med Res Pract 2020. https://doi.org/10.1016/j.cmrp.2020.03.011.
 Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TM, Pan I, Shi LB, Wang DC,
Mei J, Jiang XL. Performance of radiologists in differentiating COVID-19 from
viral pneumonia on chest CT. Radiology 2020. https://doi.org/10.1148/
 Hu Z, Ge Q, Jin L, Xiong M. Arti?cial intelligence forecasting of COVID-19 in
China. arXiv preprint arXiv:2002.07112. 2020 Feb 17.
 Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Tao Q, Sun Z, Xia L. Correlation of
chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China:
a report of 1014 cases. Radiology 2020. https://doi.org/10.1148/
 Luo H, Tang QL, Shang YX, Liang SB, Yang M, Robinson N, Liu JP. Can Chinese
medicine be used for prevention of coronavirus disease 2019 (COVID-19)? A
review of historical classics, research evidence and current prevention pro-
grams. Chin J Integr Med 2020. https://doi.org/10.1007/s11655-020-3192-6.
 Haleem A, Vaishya R, Javaid M, Khan IH. Arti?cial Intelligence (AI) applications
in orthopaedics: an innovative technology to embrace. J Clin Orthop Trauma
 Biswas K, Sen P. Space-time dependence of coronavirus (COVID-19) outbreak.
arXiv preprint arXiv:2003.03149. 2020 Mar 6.
 Stebbing J, Phelan A, Grif?n I, Tucker C, Oechsle O, Smith D, Richardson P.
COVID-19: combining antiviral and anti-in?ammatory treatments. Lancet
Infect Dis 2020 Feb 27.
 Sohrabi C, Alsa?Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, Iosi?dis C, Agha R.
World Health Organization declares global emergency: a review of the 2019
novel coronavirus (COVID-19). Int J Surg 2020 Feb 26.
 Chen S, Yang J, Yang W, Wang C, B€
arnighausen T. COVID-19 control in China
during mass population movements at New Year. Lancet 2020. https://
 Bobdey S, Ray S. Going viraleCOVID-19 impact assessment: a perspective
beyond clinical practice. J Mar Med Soc 2020 Jan 1;22(1):9.
 Gozes O, Frid-Adar M, Greenspan H, Browning PD, Zhang H, Ji W, Bernheim A,
Siegel E. Rapid ai development cycle for the Coronavirus (COVID-19)
pandemic: initial results for automated detection &patient monitoring using
deep learning ct image analysis. arXiv preprint arXiv:2003.05037. 2020 Mar
 Pirouz B, Shaf?eeHaghshenas S, Shaf?eeHaghshenas S, Piro P. Investigating a
serious challenge in the sustainable development process: analysis of
con?rmed cases of COVID-19 (new type of coronavirus) through a binary
classi?cation using arti?cial intelligence and regression analysis. Sustainabil-
ity 2020 Jan;12(6):2427.
 Ting DS, Carin L, Dzau V, Wong TY. Digital technology and COVID-19. Nat Med
2020 Mar 27:1e3.
 Wan KH, Huang SS, Young A, Lam DS. Precautionary measures needed for
ophthalmologists during pandemic of the coronavirus disease 2019 (COVID-
19). Acta Ophthalmol 2020 Mar 29.
 Li L, Qin L, Xu Z, Yin Y, Wang X, Kong B, Bai J, Lu Y, Fang Z, Song Q, Cao K.
Arti?cial intelligence distinguishes COVID-19 from community-acquired
pneumonia on chest CT. Radiology 2020 Mar 19:200905.
 Smeulders AW, Van Ginneken AM. An analysis of pathology knowledge and
decision making for the development of arti?cial intelligence-based consul-
ting systems. Anal Quant Cytol Histol 1989 Jun 1;11(3):154e65.
 Gupta R, Misra A. Contentious issues and evolving concepts in the clinical
presentation and management of patients with COVID-19 infection with
reference to use of therapeutic and other drugs used in Co-morbid diseases
(Hypertension, diabetes etc.). Diabetes, Metab Syndrome: Clin Res Rev
 Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with
diabetes in times of COVID-19 epidemic. Diabetes &Metabolic Syndrome. Clin
Res Rev 2020;14(3):211e2.
R. Vaishya et al. / Diabetes &Metabolic Syndrome: Clinical Research &Reviews 14 (2020) 337e339 339